WEDNESDAY, Dec. 27, 2023 (HealthDay News) — It may not take as strict a diet as thought to keep type 1 diabetes under control: New Swedish research shows that a moderate low-carb diet still helped people with type 1 diabetes stick to blood-sugar targets. “The study shows that a moderateContinue Reading
THURSDAY, Dec. 21, 2023 (HealthDay News) — Kids who’ve survived cancer face many health challenges, and a heightened risk for diabetes is one of them, new research shows. A team at St. Jude’s Children’s Hospital in Memphis, Tenn., reports that these children have twice the odds of developing prediabetes (aContinue Reading
WEDNESDAY, Dec. 13, 2023 (HealthDay News) — A healthy plant-based diet can reduce a person’s risk of type 2 diabetes by 24%, a new study has found. Eating plenty of fresh fruits, vegetables and whole grains has this protective effect even in people with a genetic predisposition for diabetes orContinue Reading
TUESDAY, Dec. 12, 2023 (HealthDay News) — Many Americans battling diabetes are turning to a new class of injected drugs that includes blockbusters like Ozempic (semaglutide) and Mounjaro (tirzepatide). But a new study finds half of patients who use these “second line” therapies — a class called GLP-1 RAs — quitContinue Reading
TUESDAY, Dec. 11, 2023 (HealthDay News) — The diabetes and weight-loss drug Ozempic does not appear to harm a developing fetus when taken by pregnant women, a new study reports. Researchers found no elevated risk of birth defects among newborns of women who took medications to control their type 2Continue Reading
MONDAY, Dec. 11, 2023 (HealthDay News) — Folks who take the blockbuster weight-loss med tirzepatide (Zepbound) may regain much of the weight they lost soon after discontinuing it, new research shows. A trial funded by Eli Lilly, the injected drug’s maker, found that “in patients with obesity or overweight, withdrawingContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — Could blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also lower users’ odds for colon cancer? New research suggests they might. All of these medications (and more) fall into a class of diabetes drugs known as glucagon-like peptide-1 receptorContinue Reading
THURSDAY, Dec. 7, 2023 (HealthDay News) — A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with type 1 diabetes maintain their natural ability to produce insulin,Continue Reading
WEDNESDAY, Dec. 6, 2023 (HealthDay News) — Girls whose periods begin before the age of 13 are at higher risk of becoming adult women with diabetes, compared to girls who start menstruation later, new research shows. An earlier onset of periods also appears to hike a woman’s odds for strokeContinue Reading
WEDNESDAY, Nov. 29, 2023 (Healthday News) — The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report. Both Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic the effects of the gut hormone GLP-1, which triggers insulin production, helps control appetiteContinue Reading
WEDNESDAY, Nov. 29, 2023 (HealthDay News) — People can walk away their risk of developing type 2 diabetes – but only if they walk fast enough, a new report finds. Folks who walk at least 2.5 miles an hour appear to have a significantly lower risk of type 2 diabetes,Continue Reading
TUESDAY, Nov. 14, 2023 (HealthDay News) — Women who don’t get enough sleep might have an increased risk of diabetes, an effect even more pronounced in postmenopausal females, a new study finds. Shortening sleep by just 90 minutes increased insulin resistance in women used to getting adequate sleep, researchers atContinue Reading
MONDAY, Nov. 13, 2023 (HealthDay News) — Young people who smoke and have prediabetes have triple the risk of suffering a stroke, a new study shows. Overall, hospitalized tobacco users with prediabetes had a 3.3 times higher risk that they were in the hospital due to a stroke, after researchersContinue Reading
FRIDAY, Nov. 10, 2023 (HealthDay News) — Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer. In the study, scientists found excessive insulin levels overstimulated pancreatic acinar cells, which produce digestiveContinue Reading